During the past decade, Northwest Arkansas Clinical Trials Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 15 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Arkansas Clinical Trials Center" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Amgen" with 3 trials sponsored, "Botanix Pharmaceuticals" with 2 trials sponsored, "Dermira, Inc." with 2 trials sponsored and "Galderma R&D" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Arkansas Clinical Trials Center" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Arkansas Clinical Trials Center" are "Atopic Dermatitis" (4 trials), "Plaque Psoriasis" (3 trials), "Psoriasis" (3 trials), "Acne Vulgaris" (2 trials) and "Hyperhidrosis" (2 trials). Many other conditions were trialed in "Northwest Arkansas Clinical Trials Center" in a lesser frequency.

Most popular intervention types in "Northwest Arkansas Clinical Trials Center" are "Drug" (23 trials), "Other" (9 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Lebrikizumab" (3 trials), "Apremilast" (2 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "Sofpironium Bromide Gel, 15%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Arkansas Clinical Trials Center" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Arkansas Clinical Trials Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Northwest Arkansas Clinical Trials Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Arkansas Clinical Trials Center, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".